BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:19 PM
 | 
Jun 21, 2010
 |  BC Extra  |  Company News

Valeant, Biovail merging

Biovail Corp. (TSX:BVF; NYSE:BVF) will merge with fellow specialty pharma Valeant Pharmaceuticals International (NYSE:VRX) in a deal that would give Valeant shareholders about $3.2 billion in cash and Biovail stock. Valeant shareholders will receive a cash dividend of $16.77 and 1.7809 Biovail shares per Valeant share. Biovail shareholders will own...

Read the full 238 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >